Presentation Information
[2MS-05-04]Understanding the mechanisms of resistance to molecular-targeted drugs in lung cancer using patient derived samples and molecular-dynamic simulation
○Ryohei Katayama1,2 (1. Japanese Foundation for Cancer Research, 2. The University of Tokyo)
Password required to view
orLog in
Comment
To browse or post comments, you must log in.Log in